A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes
- PMID: 2851485
- DOI: 10.1016/0378-1119(88)90593-8
A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes
Abstract
Plasmid vectors with multiple cloning sites adjacent to a vaccinia virus (VV) promoter were constructed and used to insert a protein coding sequence and a dominant selectable marker into a non-essential region of the VV genome. Recombinant viruses, selected on the basis of expression of the herpes simplex virus (HSV) thymidine kinase gene (tk), were shown to express in infected cells the model gene product, murine major histocompatibility complex (MHC) antigen H-2Kd, by cell-surface binding of antibody and by MHC-restricted recognition by cytotoxic T lymphocytes. Double recombinant VVs with insertions at two sites (in the VV tk gene and in the VV HindIII-F region) were constructed and shown to express influenza A/PR/8/34 haemagglutinin and H-2Kd antigen in addition to the HSV tk gene. The plasmids described allow the construction of recombinant VV expressing two genes of interest under the control of the same VV promoter. Such recombinant VVs can be used to study the interaction of immunologically important antigens simultaneously expressed.
Similar articles
-
Effect of in vitro mutations in a vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus.J Gen Virol. 1987 Sep;68 ( Pt 9):2299-309. doi: 10.1099/0022-1317-68-9-2299. J Gen Virol. 1987. PMID: 2821171
-
Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.Gene. 1985;35(1-2):169-77. doi: 10.1016/0378-1119(85)90169-6. Gene. 1985. PMID: 4029620
-
Construction of recombinant fowlpox viruses as vectors for poultry vaccines.Virus Res. 1988 Jun;10(4):343-56. doi: 10.1016/0168-1702(88)90075-5. Virus Res. 1988. PMID: 2842977
-
Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.Methods Mol Biol. 2004;269:31-40. doi: 10.1385/1-59259-789-0:031. Methods Mol Biol. 2004. PMID: 15114005 Review.
-
Vaccinia virus vectors for gene expression.Curr Opin Biotechnol. 1991 Oct;2(5):713-7. doi: 10.1016/0958-1669(91)90040-c. Curr Opin Biotechnol. 1991. PMID: 1367723 Review.
Cited by
-
Oncolytic Vaccinia Virus Gene Modification and Cytokine Expression Effects on Tumor Infection, Immune Response, and Killing.Mol Cancer Ther. 2021 Aug;20(8):1481-1494. doi: 10.1158/1535-7163.MCT-20-0863. Epub 2021 May 27. Mol Cancer Ther. 2021. PMID: 34045231 Free PMC article.
-
Vaccines as treatments for prostate cancer.Nat Rev Urol. 2023 Sep;20(9):544-559. doi: 10.1038/s41585-023-00739-w. Epub 2023 Mar 6. Nat Rev Urol. 2023. PMID: 36879114 Free PMC article. Review.
-
Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo.J Virol. 1996 Oct;70(10):7103-7. doi: 10.1128/JVI.70.10.7103-7107.1996. J Virol. 1996. PMID: 8794356 Free PMC article.
-
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence.J Virol. 1994 Feb;68(2):619-25. doi: 10.1128/JVI.68.2.619-625.1994. J Virol. 1994. PMID: 8289365 Free PMC article.
-
Expression of Drosophila Shaker potassium channels in mammalian cells infected with recombinant vaccinia virus.Proc Natl Acad Sci U S A. 1989 Oct;86(19):7629-33. doi: 10.1073/pnas.86.19.7629. Proc Natl Acad Sci U S A. 1989. PMID: 2477844 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials